Exome Asset Management LLC Procaps Group, S.A. Transaction History
Exome Asset Management LLC
- $115 Billion
- Q2 2024
A detailed history of Exome Asset Management LLC transactions in Procaps Group, S.A. stock. As of the latest transaction made, Exome Asset Management LLC holds 129,301 shares of PROC stock, worth $239,206. This represents 0.76% of its overall portfolio holdings.
Number of Shares
129,301Holding current value
$239,206% of portfolio
0.76%Shares
2 transactions
Others Institutions Holding PROC
# of Institutions
9Shares Held
195KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA28.9KShares$53,5350.0% of portfolio
-
United Maritime Capital LLC New York, NY14KShares$25,9000.64% of portfolio
-
State Street Corp Boston, MA12.4KShares$22,9080.0% of portfolio
-
Activest Wealth Management10KShares$18,5000.01% of portfolio
-
Royal Bank Of Canada Toronto, A6491Shares$9080.0% of portfolio
About Procaps Group, S.A.
- Ticker PROC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 112,824,000
- Market Cap $209M
- Description
- Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...